Quantitative Analysis of Hsp90-Client Interactions Reveals Principles of Substrate Recognition

Taipale, Mikko, Krykbaeva, Irina, Koeva, Martina, Kayatekin, Can, Westover, Kenneth D., Karras, Georgios I., Lindquist, Susan·2012·Cell

Cited by (879)

Items 601–700 of 879

  1. The Effects of Hsp90α1 Mutations on Myosin Thick Filament Organization
    Qiuxia He, Kechun Liu, Zhenjun Tian, Shaojun Du · 2015 · PLoS ONE
  2. Hsp90 oligomerization process: How can p23 drive the chaperone machineries?
    Eléonore Lepvrier, Michaël Nigen, Laura Moullintraffort, Sophie Chat, Diane Allegro, Pascale Barbier, Daniel Thomas, Alexis Nazabal, Cyrille Garnier · 2015 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  3. The split Renilla luciferase complementation assay is useful for identifying the interaction of Epstein-Barr virus protein kinase BGLF4 and a heat shock protein Hsp90
    J. Wang, Wenchang Guo, C. Long, H. Zhou, H. Wang, Xiukun Sun · 2016 · Acta Virologica
  4. Network-based modelling and percolation analysis of conformational dynamics and activation in the CDK2 and CDK4 proteins: dynamic and energetic polarization of the kinase lobes may determine divergence of the regulatory mechanisms
    Gennady M. Verkhivker · 2017 · Molecular BioSystems
  5. Insights into Hsp90 mechanism and in vivo functions learned from studies in the yeast, Saccharomyces cerevisiae
    Rios, Erick I., Hunsberger, Isabel L., Johnson, Jill L. · 2024 · Frontiers in Molecular Biosciences
  6. Self‐Assembled Dictamni Cortex Nanoparticles Ameliorate Psoriasis by Epigenetic Modulation of HSP90AB1 and Suppression of the Inflammatory Response
    Zhengyi Zhang, Wenqian Du, Xiaojiang Zhang, Hongbo Cui, Baochen Cheng, Xiao Han, Ke He, Tingyi Yin, Xinyi Liu, Ningyi Xian et al. · 2025 · Advanced Science
  7. Extended conformational states dominate the Hsp90 chaperone dynamics
    Alexander Jussupow, Abraham López, Mona Baumgart, Sophie L. Mader, Michael Sattler, Ville R. I. Kaila · 2022 · Journal of Biological Chemistry
  8. Role of integrin signalling through integrin‐linked kinase in skin physiology and pathology
    Beate Eckes, Thomas Krieg, Sara A. Wickström · 2014 · Experimental Dermatology
  9. Hsp90 as a therapeutic target in endocrinology: current evidence
    T. Ratajczak, Bryan K. Ward, John P. Walsh, Carmel Cluning · 2015 · Research and Reports in Endocrine Disorders
  10. The CDC37‐HSP90 chaperone complex co‐translationally degrades the nascent kinase‐dead mutant of HIPK2
    Jan Paul Müller, Karl‐Heinz Klempnauer · 2021 · FEBS Letters
  11. An intraflagellar transport dependent negative feedback regulates the MAPKKK DLK-1 to protect cilia from degeneration
    Yue Sun, Yishi Jin · 2023 · Proceedings of the National Academy of Sciences
  12. FS-93, an Hsp90 inhibitor, induces G2/M arrest and apoptosis via the degradation of client proteins in oncogene addicted and derived resistant cancer cells
    Liping Zhang, Aijun Shen, Lu Wang, Hong‐Chun Liu, Danqi Chen, Bing Xiong, Jingkang Shen, Meiyu Geng · 2015 · Oncoscience
  13. Structural Bioinformatics and Protein Docking Analysis of the Molecular Chaperone-Kinase Interactions: Towards Allosteric Inhibition of Protein Kinases by Targeting the Hsp90-Cdc37 Chaperone Machinery
    Nathan Lawless, Kristin M. Blacklock, Elizabeth Berrigan, Gennady M. Verkhivker · 2013 · Pharmaceuticals
  14. ETV6/FLT3 Fusion Is a Novel Client Protein of Hsp90
    Bùi Thị Kim Lý, Hoàng Thanh · 2018 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
  15. Ligand Binding Site Structure Shapes Folding, Assembly and Degradation of Homomeric Protein Complexes
    György Abrusán, Joseph A. Marsh · 2019 · Journal of Molecular Biology
  16. Oncogenic non-V600 mutations evade the regulatory machinery of RAF including the Cdc37/Hsp90 chaperone and the 14-3-3 scaffold
    Xiaoyu Wan, Jiajun Yap, Junjun Chen, Yifan Li, Regina Faruk, Nazereth Tan Chor Boon, Yiying Ma, Yiting Lim, Karlina Bte Jubri, Jingyi Hu et al. · 2025 · Theranostics
  17. Small molecule targeted protein degradation via the UPS: venturing beyond E3 substrate receptors
    Renyu Guo, Fukang Yang, Emily C. Cherney · 2025 · RSC Medicinal Chemistry
  18. Heat shock proteins in cerebral ischemia-reperfusion injury: Mechanisms and therapeutic implications
    Anliu Zhao, Guangming Zhang, Huayuan Wei, Yan Xu, Jiali Gan, Xijuan Jiang · 2025 · Experimental Neurology
  19. Ordered ATP hydrolysis in the Hsp90 chaperone is regulated by Aha1 and a conserved post‐translational modification
    Desmond Prah Amoah, Solomon K. Hussein, Jill L. Johnson, Paul LaPointe · 2024 · Protein Science
  20. Recent Advances in Macrocyclic Hsp90 Inhibitors
    Deborah M. Ramsey, Russell R. A. Kitson, Jeremy I. Levin, Christopher J. Moody, Shelli R. McAlpine · 2014 · Royal Society of Chemistry eBooks
  21. Sulfoxythiocarbamate S-4 inhibits HSP90 in human cutaneous squamous cell carcinoma cells
    Ying Zhang, Garrett C. VanHecke, Young‐Hoon Ahn, Charlotte M. Proby, Albena T. Dinkova‐Kostova · 2020 · European Journal of Pharmacology
  22. Protein quality control of DYRK family protein kinases by the Hsp90-Cdc37 molecular chaperone
    Yoshihiko Miyata, Eisuke Nishida · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  23. Targeting Protein Synthesis, Folding, and Degradation Pathways in Cancer
    Elisa Pasqua, Birgit Wilding, Matthew D. Cheeseman, Keith Jones · 2017 · Elsevier eBooks
  24. High-Throughput Targeted Quantitative Analysis of the Interaction between HSP90 and Kinases
    Weili Miao, Lin Li, Yinsheng Wang · 2019 · Analytical Chemistry
  25. Structural insight into guanylyl cyclase receptor hijacking of the kinase–Hsp90 regulatory mechanism
    Caveney, Nathanael A, Tsutsumi, Naotaka, Garcia, K Christopher · 2023 · eLife
  26. Molecular mechanism of PINK1 regulation by the Hsp90 machinery
    Xuyang Tian, Jiayue Su, Ziyi Wang, Tao Liu, Huifang Xiong, Shan Sun, Kunrong Mei, Sen‐Fang Sui · 2025 · Nature Communications
  27. Enniatin A Analogues as Novel Hsp90 Inhibitors that Modulate Triple-Negative Breast Cancer
    Michael A. Serwetnyk, Vincent M. Crowley, Christopher M. Brackett, Trever R. Carter, Asif Elahi, Vamsi Krishna Kommalapati, Ahmed Chadli, Brian S. J. Blagg · 2023 · ACS Medicinal Chemistry Letters
  28. Celastrol protected the MPTP-injected mice Parkinson's disease model via redox regulation of CDC37
    Wanfen Liao, Aiwen Dong, Fatima Abdul Hafeez, Qinyong Ye, En Huang · 2025 · Phytomedicine
  29. In-Cell Discovery of RNA–Protein Interactions
    Xavier Sabaté-Cadenas, Alena Shkumatava · 2020 · Trends in Biochemical Sciences
  30. Persistent Activation of mRNA Translation by Transient Hsp90 Inhibition
    Peter Tsvetkov, Timothy J. Eisen, Sven U. Heinrich, Zarina Brune, Erinc Hallacli, Gregory A. Newby, Can Kayatekin, David Pincus, Susan Lee Lindquist · 2020 · Cell Reports
  31. Hsp90 and metal‐binding J‐protein family chaperones are not critically involved in cellular iron–sulfur protein assembly and iron regulation in yeast
    Felipe A. Carvalho, Ulrich Mühlenhoff, Joseph J. Braymer, Vasilij Root, Martin Stümpfig, Carla Columbano Oliveira, Roland Lill · 2023 · FEBS Letters
  32. Differential Hsp90-dependent gene expression is strain-specific and common among yeast strains
    Po-Hsiang Hung, Chia‐Wei Liao, Fu-Hsuan Ko, Huai‐Kuang Tsai, Jun‐Yi Leu · 2023 · iScience
  33. Rational Design of Peptide Inhibitors Targeting HSP90–CDC37 Protein–Protein Interaction
    Qiuyue Zhang, Ling Yan, Yuxuan Zhang, Lixiao Zhang, Jia Yu, Qidong You, Lei Wang · 2024 · Future Medicinal Chemistry
  34. Modification of Regulatory Tyrosine Residues Biases Human Hsp90α in its Interactions with Cochaperones and Clients
    Yuantao Huo, Rishabh Karnawat, Lixia Liu, Robert A. Knieß, Maike Groß, Xuemei Chen, Matthias P. Mayer · 2024 · Journal of Molecular Biology
  35. PSKH1 kinase activity is differentially modulated via allosteric binding of Ca 2+ sensor proteins
    Christopher R. Horne, Toby A. Dite, Samuel N. Young, Lucy J. Mather, Laura F. Dagley, Jared Lee Johnson, Tomer M. Yaron, Emily M. Huntsman, Leonard A. Daly, Dominic P. Byrne et al. · 2025 · Proceedings of the National Academy of Sciences
  36. Overview of Molecular Chaperones in Health and Disease
    Tai Wang, Pablo C. Echeverría, Didier Picard · 2013 · Royal Society of Chemistry eBooks
  37. Exploiting Cancer Dependence on Molecular Chaperones
    Swee Y. Sharp, Keith Jones, Paul Workman · 2014 · Elsevier eBooks
  38. Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells
    Yue-qin Wang, Aijun Shen, Jingya Sun, Xin Wang, Hong‐Chun Liu, Minmin Zhang, Dan-Qi Chen, Bing Xiong, Jingkang Shen, Meiyu Geng et al. · 2016 · Acta Pharmacologica Sinica
  39. Picky Hsp90—Every Game with Another Mate
    Martina Radli, Stefan Rüdiger · 2017 · Molecular Cell
  40. Regulation of Kaposi’s Sarcoma-Associated Herpesvirus Biology by Host Molecular Chaperones
    Elisa Kirigin, Duncan Kyle Ruck, Zoè Jackson, James C. Murphy, Euan McDonnell, Michael Obinna Okpara, Adrian Whitehouse, Adrienne Lesley Edkins · 2020 · Heat shock proteins
  41. Hsp70-Hsp90 organising protein (HOP/STIP1) is required for KSHV lytic replication
    Elisa Kirigin, Michael Obinna Okpara, Lorraine Matandirotya, Jamie-Lee Ruck, Frederick Weaver, Zoè Jackson, Abir Chakraborty, Clinton G. L. Veale, Adrian Whitehouse, Adrienne Lesley Edkins · 2024 · Journal of General Virology
  42. Hsp90 Interacts with the Bacterial Effector NleH1
    Miaomiao Wu, Philip R. Hardwidge · 2018 · Pathogens
  43. HSP-90/kinase complexes are stabilized by the large PPIase FKB-6
    Siyuan Sima, Katalin Barkovits, Katrin Marcus, Lukas Schmauder, Stephan M. Hacker, Nils Hellwig, Nina Morgner, Klaus Richter · 2021 · Scientific Reports
  44. The KRAS p.Ala146Thr mutation promotes the proliferation of colorectal cancer cells via CDK1-mediated ERK signaling
    Wei Li, Zishan Xu, Xiangyang Dong, Xiaoyu Yang, Gaoxiang Wang, Guoyang He · 2025 · Cancer Genetics
  45. The essential co-chaperone Sgt1 regulates client dwell time in the Hsp90 chaperone cycle
    Sonja Engler, Florent Delhommel, Christopher Dodt, Abraham López, Ofrah Faust, Annika R. Elimelech, Valeria Napolitano, Grzegorz M. Popowicz, Rina Rosenzweig, Michael Sattler et al. · 2025 · Molecular Cell
  46. Hijacking client instability to selectively disrupt HSP90-driven glucocorticoid receptor activation
    Elisa Longhi, Andrea Magni, Luca Torielli, Giulia Lodigiani, Elena Carlessi, Patrizia Borsotti, Filippo Doria, Valentina Pirota, Stefano Artin Serapian, Cristina Arrigoni et al. · 2026 · Pharmacological Research
  47. CYP and SXR gene polymorphisms influence in opposite ways acute rejection rate in pediatric patients with renal transplant
    Stefano Turolo, Alberto Edefonti, Luciana Ghio, Sara Testa, William Morello, Giovanni Montini · 2020 · BMC Pediatrics
  48. Regulation of ClC-2 Chloride Channel Proteostasis by Molecular Chaperones: Correction of Leukodystrophy-Associated Defect
    Ssu-Ju Fu, Meng‐Chun Hu, Cheng-Tsung Hsiao, An-Ting Cheng, Tsung‐Yu Chen, Chung‐Jiuan Jeng, Chih‐Yung Tang · 2021 · International Journal of Molecular Sciences
  49. Lipid droplets and autophagosomes together with chaperones fine‐tune expression of SGK1
    Madiha Javeed Ghani, Wenxue Gu, Zhuyuan Chen, Cecilia M. Canessa · 2022 · Journal of Cellular and Molecular Medicine
  50. Development of machine learning models for the screening of potential HSP90 inhibitors
    Mohd Imran Khan, Taehwan Park, Mohammad Azhar Imran, Venu Venkatarame Gowda Saralamma, Duk‐Chul Lee, Jaehyuk Choi, Mohammad Hassan Baig, Jae-June Dong · 2022 · Frontiers in Molecular Biosciences
  51. Functional analysis reveals driver cooperativity and novel mechanisms in endometrial carcinogenesis
    Matthew Brown, Alicia Leon, Katarzyna Kedzierska, C. Moore, Hayley L. Belnoue-Davis, Susanne Flach, John P. Lydon, Francesco John DeMayo, Annabelle Lewis, Tjalling Bosse et al. · 2023 · EMBO Molecular Medicine
  52. Protective role of the HSP90 inhibitor, STA-9090, in lungs of SARS-CoV-2-infected Syrian golden hamsters
    Luiz Gustavo Teixeira Alves, Morris Baumgardt, Christine Langner, Mara Fischer, Julia Maria Adler, Judith Bushe, Theresa C. Firsching, Guido Mastrobuoni, Jenny Grobe, Katja Hönzke et al. · 2024 · BMJ Open Respiratory Research
  53. Dual-Site Targeting by Peptide Inhibitors of the N-Terminal Domain of Hsp90: Mechanism and Design
    Min Zang, Haipeng Gan, Xuejie Zhou, Lei Wang, Hao Dong · 2025 · Journal of Chemical Information and Modeling
  54. Computational Studies of Allosteric Regulation in the Hsp90 Molecular Chaperone: From Functional Dynamics and Protein Structure Networks to Allosteric Communications and Targeted Anti‐Cancer Modulators
    Gennady M. Verkhivker · 2014 · Israel Journal of Chemistry
  55. Hsp90: Is There an Unknown Role in Pain Neurobiology
    João Dias-Ferreira, Fani Lourença Moreira Neto · 2019 · Heat shock proteins
  56. Peptides in proteins
    Benedikt Weber, Andreas Maier, Johannes Büchner · 2019 · Journal of Peptide Science
  57. Dissecting Molecular Principles of the Hsp90 Chaperone Regulation by Allosteric Modulators Using a Hierarchical Simulation Approach and Network Modeling of Allosteric Interactions: Conformational Selection Dictates the Diversity of Protein Responses and Ligand-Specific Functional Mechanisms
    Lindy Astl, Gabrielle Stetz, Gennady M. Verkhivker · 2020 · Journal of Chemical Theory and Computation
  58. Down‑regulated G protein‑coupled receptor kinase 6 leads to apoptosis in multiple myeloma MM1R cells
    Zhiyao Zhang, Zhenyu Li, Wen-Ming Chen · 2018 · Experimental and Therapeutic Medicine
  59. Identification of up‐regulated transcripts during Pleurotus ostreatus primordium stage and characterization of PoALDH1
    Yuancheng Qi, Xiankai Sun, Mengke Zhang, Qing Wen, Liyou Qiu, Jinwen Shen · 2018 · Journal of Basic Microbiology
  60. Using Caenorhabditis elegans to Screen for Tissue-Specific Chaperone Interactions
    Shiran Dror, Tomer Dvir Meidan, Ido Karady, Anat Ben‐Zvi · 2020 · Journal of Visualized Experiments
  61. The cellular pathways that maintain the quality control and transport of diverse potassium channels
    Nga H. Nguyen, Jeffrey L. Brodsky · 2023 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  62. Progress in Molecular Chaperone Regulation of Heat Shock Protein 90 and Cancer
    ZHAI Rui, Gong Xiao-Yun, XIONG Xing-Chuang, You Jiang, Zejian Huang, Fang Xiang · 2018 · Chinese Journal of Analytical Chemistry
  63. The role of Aha1 in cancer and neurodegeneration
    Brian S. J. Blagg, Kevin C. Catalfano · 2024 · Frontiers in Molecular Neuroscience
  64. Decoding cellular stress states for toxicology using single-cell transcriptomics
    Imran Shah, David A. Gallegos, Brian Robinette, Bryant A. Chambers, Dennis J. Eastburn, Douglas A. Bell, Michelle R. Campbell, Suzanne N. Martos, Salvatore Camiolo, Kevin S. White et al. · 2025 · NAM journal.
  65. Targeted protein degradation of HSP90 and associated proteins for cancer therapy via PROTACs and beyond
    Gulshan Kumar, Gouri Tyagi, Vikramdeep Monga · 2025 · RSC Medicinal Chemistry
  66. Targeting Cell division cycle 37: A Promising Novel Therapeutic Strategy
    Lixiao Zhang, Yuting Xin, Qidong You, Lei Wang · 2025 · ChemMedChem
  67. Diversified design strategies for small-molecule PROTACs: How do we select?
    Qingsong Chen, Jian-Hua Liang · 2026 · European Journal of Medicinal Chemistry
  68. The evolution of heat shock protein 90 C-terminal inhibitors: From novobiocin to potential clinical candidates
    Xiaosheng Jiang, Brian S. J. Blagg · 2026 · Cell Stress and Chaperones
  69. Hsp90: A means to an end
    Katie M. Whalen, Brian Freeman · 2026 · Cell Stress and Chaperones
  70. Structural basis for chaperone-guided assembly of RNA-induced silencing complex
    Young-Yoon Lee, Minseok Jeong, Hansol Lee, Daniel Lee, Jaehyun Lee, Junsun Park, V. Narry Kim, Soung‐Hun Roh · 2026 · Nature
  71. Curcumin derivative C210 induces Epstein–Barr virus lytic cycle and inhibits virion production by disrupting Hsp90 function
    Linli Chen, Xiaojing Guo, Wen Lin, Yingying Huang, Suling Zhuang, Qianfeng Li, Jianhua Xu, Shengnan Ye · 2024 · Scientific Reports
  72. Therapeutic targeting of HSP90 in herpesvirus infections, past and future challenges
    Abir Chakraborty, Pia Roos‐Mattjus, Silvia Gramolelli · 2025 · Transactions of the Royal Society of South Africa
  73. Nanomaterial-assisted immunodiagnostic profiling and therapeutic targeting of hepatocellular carcinoma: from molecular biomarkers to clinical applications
    Jiping Luo, Jianzeng Ye, Kaipeng Huang, Ziyu Cheng, L.-Z. Liu, Xianpeng Li · 2025 · Frontiers in Immunology
  74. The Hsp90 Chaperone Machinery: An Important Hub in Protein Interaction Networks
    Jürgen Radons · 2016 · Journal of Advances in Medicine and Medical Research
  75. Hsp90 Chaperone in Disease
    Luca Ferrari, Stefan Rüdiger · 2019 · Heat shock proteins
  76. Molecular Insight into the Extracellular Chaperone Serum Albumin in Modifying the Folding Free Energy Landscape of Client Proteins
    Yangzhuoyue Jin, Gangjin Yu, Tairan Yuwen, Dawei Gao, Guan Wang, Yilin Zhou, Bin Jiang, Xu Zhang, Conggang Li, Lichun He et al. · 2022 · The Journal of Physical Chemistry Letters
  77. Protein–Protein Interactions in Cancer
    Krishna Mohan Poluri, Khushboo Gulati, Deepak Kumar Tripathi, Nupur Nagar · 2023 · Springer eBooks
  78. Involvement of mTOR signaling in physiopathology and its potential therapeutic interventions
    Irene Martín-Bocanegra, Thaissa L Horne, Belén Maqueda-Hernández, Elena Navarro‐Villarán, Jordi Muntané · 2023 · Redox Experimental Medicine
  79. Characterization of HSP90 expression and function following CNS injury
    Chaohua Fu, Yaling Lei, Lin Liang, Jianxiong Jiang, Ying Qin, Yongbin Lao, Zhiwen Tan, Yuansheng Wang, Qiuling Liu · 2024 · Neuroscience Letters
  80. Quantitative Profiling of Chaperone/Client Interactions with LUMIER Assay
    Mikko Taipale · 2017 · Methods in molecular biology
  81. An ELISA-based platform for rapid identification of structure-dependent nucleic acid–protein interactions detects novel DNA triplex interactors
    Nicholas G. Economos, Upasna Thapar, Nanda Balasubramanian, Georgios Ioannis Karras, Peter M. Glazer · 2022 · Journal of Biological Chemistry
  82. The transportosome system as a model for the retrotransport of soluble proteins
    Gisela I. Mazaira, Alejandra G. Erlejman, Nadia R. Zgajnar, Graciela Piwien‐Pilipuk, Mario D. Galigniana · 2023 · Molecular and Cellular Endocrinology
  83. Mitophagy-related genes could facilitate the development of septic shock during immune infiltration
    Yu-Shen Yang, Wan-Jing Zheng, Chu-Yun Liu, Wei-can Chen, Wen-Xi Xie, He‐fan He · 2023 · Medicine
  84. The Interaction Network of the Hsp90 Molecular Chaperone
    Kamran Rizzolo, Philip Wong, Elisabeth R.M. Tillier, Walid A. Houry · 2014 · Springer eBooks
  85. Evaluating Dual Hsp90 and Hsp70 Inhibition as a Cancer Therapy
    Laura K. Buckton, Yao Wang, Jeanette R. McConnell, Shelli R. McAlpine · 2015 · Topics in medicinal chemistry
  86. Effect of SNX-2112 on proliferation of esophageal cancer cells via regulation of excision repair cross-complementing 1, epidermal growth factor receptor, and p53 expression
    C.Y. Li, Y.J. Ren, Y.D. Li · 2016 · Genetics and Molecular Research
  87. Oncogenic acidic nuclear phosphoproteins ANP32C/D are novel clients of heat shock protein 90
    Yuliia Yuzefovych, Rainer Blasczyk, Trevor Huyton · 2015 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  88. The Investigation of Hsp90C‐Terminal Inhibitors Containing Amide Bioisosteres
    Eva Amatya, Chitra Subramanian, Reagan Long, Kelli McNamara, Mark Steven Cohen, Brian S. J. Blagg · 2024 · ChemMedChem
  89. Purification and characterization of full-length monomeric TEC family kinase, ITK
    Udumbara M. Rathnayake, Junya Wada, Vanessa E. Wall, Jane E. Jones, Lisa M. Miller Jenkins, Amy Hamilton Andreotti, Lawrence E. Samelson · 2025 · Protein Expression and Purification
  90. Dissecting the Cdc37 cochaperone code: Functional roles in chaperone-mediated stress adaptation
    Megan M. Mitchem, Ashley Choi, Duhita A Mirikar, Rajlekha Deb, Andrew W. Truman · 2025 · Journal of Biological Chemistry
  91. HSP90 inhibitors beyond oncology: optimization and mechanism insights in non-oncological diseases
    Xingyu Yin, Huangliang Shu, Danni Wang, Qidong You, Qiuyue Zhang, Lei Wang · 2025 · Drug Discovery Today
  92. Hsp90 β ‐Selective Inhibitors: Probing the Solvent‐Accessible Frontier
    Terin D’Amico, Michael A. Serwetnyk, Xiaozheng Dou, Ian Mersich, Deborah J. Barlow, Karen L. Houseknecht, John M. Streicher, Aktar Ali, Brian S. J. Blagg · 2025 · ChemMedChem
  93. Targeting the protein–protein interaction between the CDC37 cochaperone and client kinases by an allosteric RAF dimer breaker
    Alison Yu, Shrhea Banerjee, Sravani Malasani, Bamidele Toheeb Towolawi, Zhiwei Liu, Zhihong Wang · 2025 · Journal of Biological Chemistry
  94. Development of a chaperone-mediated protein degrader targeting ERK5 that efficaciously reduces tumor growth
    Xiangcai Yang, Wei Yin, Mengmeng Xu, Ignazia Tusa, Alessio Menconi, Yan Dai, Qinglin Ding, Guoqiang Wang, Kevin P. Foley, Elisabetta Rovida et al. · 2026 · Cell Communication and Signaling
  95. Intersections between proteostasis and immunity: insights from Caenorhabditis elegans
    Emily R. Troemel, Patricija van Oosten‐Hawle, Michalis Barkoulas · 2026 · Disease Models & Mechanisms
  96. Targeting HSP90 suppresses STAT1/CCL8-driven inflammation and mitigates mitochondrial dysfunction to attenuate hypertension-induced atrial fibrillation
    Yao Li, Jiawei Wu, Bo Xing, Mingzhi Wan, Yiwen Wang, Nana Qin, Zijun Zhou, J Y Li, Liming Yu, Huishan Wang · 2026 · Life Sciences
  97. Heat Shock Protein 90: From Molecular Chaperone Function to Therapeutic Targeting in Malignancies
    Beibei Zhang, Xinxin Zou, Jiansong Zhou, Qinmiao Sun, Dahua Chen · 2026 · Advanced Science
  98. Human J-domain proteins promote stress granule disassembly and suppress neurodegeneration-linked protein aggregation
    Giovanni J. Mastromarco, Rebecca Earnshaw, Gaelen Moore, X.Y. Sherwin Xu, Nour H. Sadek, Fiona Cui, Natalie Lo, Hyun O. Lee · 2026 · Cell Reports
  99. Nuclear ERK5 inhibits progression of leukemic monocytes to macrophages by regulating the transcription factor PU.1 and heat shock protein HSP70
    Ruifang Zheng, George P. Studzinski · 2016 · Leukemia & lymphoma/Leukemia and lymphoma
  100. Conserved Water Molecule-dependent Docking Strategy and Atom-Based 3D QSAR Studies to Design Heat Shock Protein 90 Inhibitors
    Sayan Dutta Gupta, C.V.S. Subrahmanyam, N. L. Gowrishankar, Nulgumnalli Manjunathaiah Raghavendra · 2020 · Indian Journal of Pharmaceutical Sciences